Physician

Nicholas J Mandalakas, M.D.

According to 2025 Medicare claims, Nicholas Mandalakas, M.D. (NPI: 1811988868) practices cardiology in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is CARDIOLOGY PHYSICIANS, LLC (NPI: 1952338212; TIN: 510363108) and primary practice location at 19901-4103. Mandalakas is affiliated with the UM ACO (ACO ID: A2754), eBrightHealth ACO (ACO ID: A3053), and AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Mandalakas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,906 traditional Medicare patients, billed 5,875 HCPCS/CPT codes, and received $269,410 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,709 prescription claims across 251 beneficiaries totaling $442,276 in drug costs, led by Eliquis (Apixaban). DME data shows 18 claims. Open Payments data shows 45 records totaling $3,450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $197,814 to $269,410. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $206,170 and ending at $442,276. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,342	4,109	$197,814
2016	1,653	4,018	$182,269
2017	969	2,558	$116,731
2018	1,019	2,545	$109,346
2019	794	2,274	$98,756
2020	1,261	3,517	$227,886
2021	1,241	2,826	$164,752
2022	1,799	5,949	$260,396
2023	1,950	6,700	$319,309
2024	1,906	5,875	$269,410

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	381	2,751	$206,170
2016	383	2,388	$239,992
2017	415	2,617	$269,444
2018	336	1,993	$222,662
2019	278	1,844	$303,560
2020	268	822	$170,863
2021	191	870	$190,036
2022	192	726	$179,156
2023	204	1,248	$302,797
2024	251	1,709	$442,276

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$86,326
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$61,045
2024	N/R	18	$44,449

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	241	351	$89
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	186	190	$50
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	212	666	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	258	351	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,383	1,787	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	153	10,151	$194,017
Jardiance	Empagliflozin	57	3,930	$74,903
Xarelto	Rivaroxaban	43	3,600	$64,738
Entresto	Sacubitril/Valsartan	23	1,350	$29,813
Repatha Sureclick	Evolocumab	19	1,008	$18,850

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	18	$44,449

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$3,450	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas J. Mandalakas, M.D.?

Tedicare shows public-source Medicare data for Nicholas J. Mandalakas, M.D. (NPI 1811988868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas J. Mandalakas, M.D. have ACO affiliation data?

Nicholas J. Mandalakas, M.D. is shown with ACO affiliation data for UM ACO (MSSP, ACO ID A2754), eBrightHealth ACO (MSSP, ACO ID A3053), and AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Nicholas J. Mandalakas, M.D.?

Nicholas J. Mandalakas, M.D. is linked to CARDIOLOGY PHYSICIANS, LLC (billing NPI 1952338212) in the available physician profile data.

Does Nicholas J. Mandalakas, M.D. have Open Payments data?

Nicholas J. Mandalakas, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.